Anteris Technologies CEO Wayne Paterson Talks JustStocks Video Through 2024 Milestones Following $23 Million Raise

Anteris Technologies Ltd (ASX: AVR) CEO Wayne Paterson speaks with JustStocks Video soon after announcing the completion of a $23 million placement. The company’s lead product, DurAVR, is a transcatheter heart valve for treating aortic stenosis. It has so far been implanted in 50 patients. Paterson says the clinical results to date demonstrate this new class of biomimetic valve outperforms the market leader. The additional capital will be put towards preparing for the DurAVR FDA pivotal study – a key step towards gaining regulatory clearance for the US market.

Articles of Interest